Use of procalcitonin measurement to identify bacterial co-infection in patients with H1N1 influenza

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 4, 2010, Pages 487-488

  Eisenhut, M ^a  

^a LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

HUMAN; INFLUENZA; INFLUENZA A (H1N1); LETTER; MEASUREMENT; MIXED INFECTION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; CALCITONIN; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PNEUMOCOCCAL INFECTIONS; PROTEIN PRECURSORS; STREPTOCOCCUS PNEUMONIAE;

EID: 77649218352     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01663.x     Document Type: Letter

References (3)

1. Oezkaya E, Cambaz N, Coskun Y, Mete F, Gyik M, Samanci N. The effect of rapid diagnostic testing for influenza on the reduction of antibiotic use in paediatric emergency department. Acta Paediatr 2009 98 : 1589 1592.
2. Klugman KP, Chien Y-W, Madhi SA. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 2009 275 : C9 14.
3. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomised controlled trial. JAMA 2009 302 : 1059 1066.